The Warnings Page: Lamisil, Effexor, Serzone and More in the News
September 30, 2003
FDA Orders Novartis to Pull
TV Advertisements for Lamisil
The FDA issued a letter ordering Novartis Pharmaceuticals Corp., to withdraw Lamisil advertisements featuring "Digger," an animated dermatophyte, after finding that it and similar promotional materials violated of the Food, Drug, and Cosmetic Act.
The 60-second commercial and related promotions, which many Americans found disturbing due to its graphic portrayal of toenail infections, overstated the efficacy of the drug, minimized information regarding the drug's side effects, and made unsubstantiated superiority claims about Lamisil, the federal agency's Aug. 22 letter stated.
"The TV ads overstate the efficacy of Lamisil through their …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach